FIELD: medicine, in particular, in particular pharmaceutical industry, namely liposomal interferon inducer.
SUBSTANCE: claimed liposomal interferon inducer represents aqueous-saline solution of double-strand RNA, obtained from killer yeast Saccharomyces cerevisia strains, single-strand eupolymer yeast RNA, phosphatidyl choline, cholesterole, alpha-tocopherol acetate, sucrose and sodium chloride.
EFFECT: inducer with increased activity at peroral administration.
| Title | Year | Author | Number |
|---|---|---|---|
| PROLONGED-EFFECT INTERFERON INDUCTOR | 1999 |
|
RU2172631C2 |
| SOAPY AMPHIPHILIC INTERFERON GAMMA INDUCER PENETRATING READILY THROUGH BIOLOGICAL MEMBRANES | 2012 |
|
RU2496783C1 |
| METHOD FOR PRODUCTION OF DOUBLE-HELICAL RIBONUCLEIC ACID | 2003 |
|
RU2302464C2 |
| LIPOSOMAL PERORAL ANTIVIRAL TREATMENT-AND-PROPHYLACTIC AGENT ON BASIS OF HUMAN INTERFERON ALPHA | 2008 |
|
RU2361572C1 |
| ANTIVIRAL MEDICINAL PREPARATION | 2003 |
|
RU2255735C2 |
| INTERFERON INDUCTOR SUPPOSITORIES | 2005 |
|
RU2328272C2 |
| METHOD OF TREATING RECURRENT GENITAL HERPES WITH CHRONIC FATIGUE SYMPTOMS | 2012 |
|
RU2492861C1 |
| METHOD FOR PRODUCING LIPID MIXTURE AND LIPOSOMAL ORAL ANTIVIRAL THERAPEUTIC AND PROPHYLACTIC AGENT USING SAID LIPID MIXTURE | 2020 |
|
RU2746320C1 |
| RIDOSTIN AS INTERFERON INDUCTOR | 1993 |
|
RU2083221C1 |
| NEW APPLICATION OF NATURAL DOUBLE-STRANDED RNAS FOR THE TREATMENT AND/OR PREVENTION OF VIRAL INFECTIONS | 2022 |
|
RU2781903C1 |
